Impact of Nuun Electrolyte Tablets on Hydration Status in Active Men and Women

April 26, 2021 updated by: Richard Bloomer, University of Memphis

Impact of Nuun Electrolyte Tablets on Hydration Status in Active Men and Women: Single-blinded Study

The purpose of this study is to determine the impact of Nuun electrolyte tablets on hydration status in young and active men and women. We will follow a similar approach as used by Maughan and colleagues (2016) to measure the beverage hydration index (the relative amount of urine passed after consumption of a drink compared to water). It is hypothesized that Nuun electrolyte tablets will result in a greater hydration status as compared to water only. Due to the fact that athletes use Nuun tablets at varying dosages, we will evaluate Nuun at both a single dosage and a double dosage. We maintain a non-directional hypothesis regarding the potential differences between the two different dosages tested.

Study Overview

Status

Completed

Conditions

Detailed Description

Maintaining adequate hydration is essential to optimal health and athletic performance. When individuals exercise (in particular in a warm environment), they can lose excessive amounts of fluids through sweating, along with necessary electrolytes (e.g., sodium, potassium, chloride). With dehydration, individuals may feel sluggish and can experience impaired physical performance.

Many attempts have been made to improve and measure the hydration status of active individuals. This typically involves the ingestion of fluids leading up to activity (typically plain water), as well as the ingestion of fluids during the activity itself (water, along with a diluted carbohydrate/electrolyte beverage). This approach seems to work well; however, some debate remains over what the best fluid is to consume, in particular related to the macronutrient type and the specific electrolyte mix.

Related to the above, it is well-accepted that electrolyte replenishment is of importance, both during and following exercise-to aid in rehydration for subsequent bouts. The use of electrolytes (sodium in particular) has been used for decades to aid athlete hydration and has led to the development of various sport drinks-which also include small amounts of carbohydrate. However, one problem with carbohydrate ingestion is that some individuals experience gastrointestinal (GI) upset following carbohydrate ingestion before and during an event, despite very good physical performance outcomes. Due to this GI upset, some individuals (in particular recreationally active individuals who are not competing at high levels) rely solely on water and seek a method to ingest the lost electrolytes. In addition, some individuals prefer to have both plain water and an electrolyte beverage during their training/competition sessions and in some activities (e.g., running, cycling), carrying multiple bottles of fluid is difficult.

The solution to the above issues for many athletes is the use of electrolyte tablets. These can be dropped into plain water and will dissolve into a flavored electrolyte-rich beverage. They are easy to transport and provide the needed electrolytes to replace those that are lost through intense and/or long duration exercise.

Nuun electrolyte tablets provide only 2 grams of carbohydrate and a combination of electrolytes, provided at a relatively low percentage of the Daily Value (DV). The DV tells us how much a particular nutrient in a serving of a food product contributes to a daily diet, based on a standard 2000 calorie diet. Nuun tablets contain: calcium (13mg, 1%DV), sodium (300mg, 13%DV), potassium (150mg, 3%DV), magnesium (25mg, 6%DV), and chloride (40mg, 2%DV). These tablets contain a small percentage of the needed total electrolytes but adequate amounts to replace lost electrolytes as a result of physical activity.

While Nuun tablets are commercially available and have received positive reviews from end users, there have been no studies to date to evaluate the impact of these tablets on hydration status. Therefore, the purpose of this study is to determine the impact of Nuun electrolyte tablets on hydration status in young and active men and women. We will follow a similar approach as used by Maughan and colleagues to measure the beverage hydration index (the relative amount of urine passed after consumption of a drink compared to water). It is hypothesized that Nuun electrolyte tablets will result in a greater hydration status as compared to water only. Due to the fact that athletes use Nuun tablets at varying dosages, we will evaluate Nuun at both a single dosage and a double dosage. We maintain a non-directional hypothesis regarding the potential differences between the two different dosages tested.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Memphis, Tennessee, United States, 38152
        • Center for Nutraceutical and Dietary Supplement Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 18.5 and 29.9 kg/m2 (not obese)
  • Consumes 2 liters of water daily
  • Exercised 3 hours/week over the past 6 months

Exclusion Criteria:

  • Obese
  • Pregnant or trying to become pregnant
  • Tobacco user
  • Cardiac Disease
  • Consumed alcohol within 48 hours of testing visit
  • Consumed caffeine within 48 hours of testing visit
  • Strenuous excercise 24 hours prior to testing visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nuun Single strength
3 Nuun electrolyte tablets will be dissolved in 1.4 liters of water. Subjects will drink one liter of the prepared solution over 30 min (250 mL every 7.5 min)
Each table contains 2 grams of carbohydrate and a combination of electrolytes. calcium (13mg, 1%DV), sodium (300mg, 13%DV), potassium (150mg, 3%DV), magnesium (25mg, 6%DV), and chloride (40mg, 2%DV).
water
Experimental: Nuun Double strength
6 Nuun electrolyte tablets will be dissolved in 1.4 liters of water. Subjects will drink one liter of the prepared solution over 30 min (250 mL every 7.5 min)
Each table contains 2 grams of carbohydrate and a combination of electrolytes. calcium (13mg, 1%DV), sodium (300mg, 13%DV), potassium (150mg, 3%DV), magnesium (25mg, 6%DV), and chloride (40mg, 2%DV).
water
Placebo Comparator: Control
Subjects will drink one liter of water over 30 min (250 mL every 7.5 min)
water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight
Time Frame: baseline
Body weight will be measured
baseline
Body weight
Time Frame: 4 hours after drink consumption
Body weight will be measured
4 hours after drink consumption
Urine volume
Time Frame: Immediately after completing intervention
Volume of urine output will be measured
Immediately after completing intervention
Urine volume
Time Frame: 1 hour after intervention
Volume of urine output will be measured
1 hour after intervention
Urine volume
Time Frame: 2 hours after intervention
Volume of urine output will be measured
2 hours after intervention
Urine volume
Time Frame: 3 hours after intervention
Volume of urine output will be measured
3 hours after intervention
Urine volume
Time Frame: 4 hours after intervention
Volume of urine output will be measured
4 hours after intervention
Urine mass
Time Frame: Immediately after completing intervention
Urine output will be measured using a scale
Immediately after completing intervention
Urine mass
Time Frame: 1 hour after intervention
Urine output will be measured using a scale
1 hour after intervention
Urine mass
Time Frame: 2 hours after intervention
Urine output will be measured using a scale
2 hours after intervention
Urine mass
Time Frame: 3 hours after intervention
Urine output will be measured using a scale
3 hours after intervention
Urine mass
Time Frame: 4 hours after intervention
Urine output will be measured using a scale
4 hours after intervention
Blood Pressure
Time Frame: at baseline
Blood pressure will be measured.
at baseline
Blood Pressure
Time Frame: 1 hour after intervention
Blood pressure will be measured.
1 hour after intervention
Blood Pressure
Time Frame: 2 hours after intervention
Blood pressure will be measured.
2 hours after intervention
Blood Pressure
Time Frame: 3 hours after intervention
Blood pressure will be measured.
3 hours after intervention
Blood Pressure
Time Frame: 4 hours after intervention
Blood pressure will be measured.
4 hours after intervention
Heart Rate
Time Frame: baseline
Heart Rate will be measured
baseline
Heart Rate
Time Frame: 1 hour after intervention
Heart Rate will be measured
1 hour after intervention
Heart Rate
Time Frame: 2 hours after intervention
Heart Rate will be measured
2 hours after intervention
Heart Rate
Time Frame: 3 hours after intervention
Heart Rate will be measured
3 hours after intervention
Heart Rate
Time Frame: 4 hours after intervention
Heart Rate will be measured
4 hours after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2020

Primary Completion (Actual)

August 18, 2020

Study Completion (Actual)

August 18, 2020

Study Registration Dates

First Submitted

June 4, 2020

First Submitted That Met QC Criteria

June 4, 2020

First Posted (Actual)

June 9, 2020

Study Record Updates

Last Update Posted (Actual)

April 28, 2021

Last Update Submitted That Met QC Criteria

April 26, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PRO-FY2020-327

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hydration

Clinical Trials on Nuun electrolyte tablet

Subscribe